Differential impact of perfluorochemical physical properties on the physiologic, histologic, and inflammatory profile in acute lung injury

Critical Care Medicine

Volumn 33, Issue 5, 2005, Pages 1096-1103

  Shashikant, Beth N ^a   Miller, Thomas L ^a,b   Jeng, Mei Jy ^c   Davis, Jonathan ^d   Shaffer, Thomas H ^a,b   Wolfson, Marla R ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Acute lung injury; Interleukin 8; Lung function; Myeloperoxidase; Partial liquid ventilation; Perfluorochemical

Indexed keywords

INTERLEUKIN 8; MYELOPEROXIDASE; PERFLUORO COMPOUND;

ACUTE LUNG INJURY; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL BLOOD; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CHEMISTRY; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; GAS EXCHANGE; HISTOPATHOLOGY; INFLAMMATION; LIQUID VENTILATION; LUNG FUNCTION; LUNG MECHANICS; LUNG PARENCHYMA; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RABBIT; VAPOR PRESSURE; VISCOSITY;

ANIMALS; FLUOROCARBONS; INTERLEUKIN-8; LIQUID VENTILATION; PEROXIDASE; RABBITS; RESPIRATORY DISTRESS SYNDROME, ADULT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 18344397030     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000163218.79770.29     Document Type: Article

References (49)

1. Wolfson MR, Greenspan JS, Shaffer TH: Liquid-assisted ventilation: An alternative respiratory modality. Pediatr Pulmonol 1998; 26:42-63
2. Greenspan JS, Wolfson MR, Rubenstein SD, et al: Liquid ventilation of human preterm neonates. J Pediatr 1990; 117:106-111
3. Gauger PG, Pranikoff T, Schreiner RJ, et al: Initial experience with partial liquid ventilation in pediatric patients with acute respiratory distress syndrome. Crit Care Med 1996; 24:16-22
4. Rossman JE, Caty MG, Rich GA, et al: Neutrophil activation and chemotaxis after in vitro treatment with perfluorocarbon. J Pediatr Surg 1996; 31:1147-1151
5. Varani J, Hirschl RB, Dame M, et al: Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an intro model of liquid ventilation therapy. Shock 1996; 6:339-344
6. Smith TM, Steinhorn DM, Thusu K, et al: A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit Care Med 1996; 23:1533-1539
7. Steinhorn DM, Smith TM, Fuhrman BP: Perflubron decreases nitric oxide (NO) production by alveolar macrophages (AM) in vitro. Pediatr Res 1995; 4:315
8. Kornbrust E, Xu A, Nesland G, et al: Perflubron (LiquiVent) attenuates neutrophil adhesion to activated endothelial cells in vitro. Am J Respir Crit Care Med 1997; 155:622
9. Thomassen MJ, Buhrow LT, Wiedemann HP: Perflubron decreases inflammatory cytokine production by human alveolar macrophages. Crit Care Med 1997; 25:2045-2047
10. von der Hardt K, Schoof E, Kandler MA, et al: Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr Res 2002; 51:177-182
11. Kandler MA, von der Hardt K, Schoof E, et al: Persistent improvement of gas exchange and lung mechanics by aerosolized perfluorocarbon. Am J Respir Crit Care Med 2001; 164:31-35
12. von der Hardt K, Kandler MA, Brenn G, et al: Comparison of aerosol therapy with different perfluorocarbons in surfactant-depleted animals. Crit Care Med 2004; 32:1200-1206
13. Woods CM, Neslund G, Kornbrust E, et al: Perflubron attenuates neutrophil adhesion to activated endothelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 2000; 278: L1008-L1017
14. Miller TF, Milestone B, Stern R, et al: Effects of perfluorochemical distribution and elimination dynamics on cardiopulmonary function. J Appl Physiol 2001; 90:839-849
15. Obratsov VV, Neslund GG, Kornbrust ES, et al: In vitro cellular effects of perfluorochemicals correlate with their lipid solubility. Am J Physiol Lung Cell Mol Physiol 2000; 278: L1018-L1024
16. Gabriel JL, Miller TF, Wolfson MR, et al: Quantitative structure-activity relationship of perfluorinated hetero-hydrocarbons as potential respiratory media: Application to oxygen solubility, log P, viscosity, vapor pressure and density. ASAIO J 1996; 42:968-973
17. Jeng MJ, Yang SS, Wolfson MR, et al: Perfluorochemical (PFC) combinations for acute lung injury: An in vitro and in vivo study in juvenile rabbits. Pediatr Res 2003; 53:81-88
18. Lachmann B, Robertson B, Vogel J: In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesth Scand 1980; 24:231-236
19. Al-Rahmani A, Awad K, Miller TF, et al: Effects of partial liquid ventilation with perfluorodecalin in the juvenile rabbit lung after saline injury. Crit Care Med 2000; 28:1459-1464
20. Bhutani VK, Sivieri EM, Abbasi S, et al: Evaluation of neonatal pulmonary mechanics and energetics: A two-factor least mean square analysis. Pediatr Pulmonol 1988; 4:150-158
21. Shaffer TH, Wolfson MR, Clark LC Jr: State-of-the-art: Liquid ventilation. Pediatr Pulmonol 1992; 14:102-109
22. Davidson A, Heckman JL, Donner R, et al: Cardiopulmonary interaction during partial liquid ventilation in surfactant treated preterm lambs. Eur J Pediatr 1997; 157:138-145
23. Jeng MJ, Oliver R, Wolfson MR, et al: Partial liquid ventilation: Effect of initial dose and redosing strategy in acute lung injury. Pediatr Crit Care Med 2002; 3:163-170
24. Boynton BR, Carlo WA, Jobe AH (Eds): New therapies for neonatal respiratory failure. Boston, Cambridge University Press, 1994, pp 1-185
25. Notter RH, Egan EA, Kwong MS, et al: Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: Effects of dose, dispersion technique and gestational age. Pediatr Res 1985; 19:569-577
26. Schierwagen C, Bylund-Fellenius A, Lundberg C: Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 1990; 23:179-186
27. Wolfson MR, Kechner NE, Roache RF, et al: Perfluorochemical rescue after surfactant treatment: Effect of perflubron dose and ventilatory frequency. J Appl Physiol 1998; 84:624-640
28. Deoras KS, Wolfson MR, Searls RL, et al: Use of a touch sensitive screen and computer assisted image analysis for quantitation of developmental changes in pulmonary structure. Pediatr Pulmonol 1990; 9:109-118
29. Wolfson MR, Greenspan JS, Deoras KS, et al: Comparison of gas and liquid ventilation: Clinical, physiological, and histological correlates. J Appl Physiol 1992; 72:1024-1031
30. Leach CL, Greenspan JS, Rubenstein SD, et al: Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med 1996; 335:761-767
31. Shaffer TH, Foust R, Wolfson MR, et al: Analysis of perfluorochemical elimination from the respiratory system. J Appl Physiol 1997; 83:1033-1040
32. Curtis SE, Peek JT, Kelly DR: Partial liquid breathing with perflubron improves arterial oxygenation in acute canine lung injury. J Appl Physiol 1993; 75:2696-2702
33. Leach CL, Fuhrman BP, Morin FC, et al; Perfluorocarbon-associated gas exchange (partial liquid ventilation) in respiratory distress syndrome: A prospective, randomized, controlled study. Crit Care Med 1993; 21:1270-1278
34. Tutuncu AS, Faithfull NS, Lachmann B: Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: Dose-dependent improvement of gas exchange. Crit Care Med 1993; 21:962-969
35. Leach CL, Greenspan JS, Rubenstein SD, et al: Partial liquid ventilation with LiquiVent: A pilot and safety and efficacy study in premature newborns with severe respiratory distress syndrome (RDS). Pediatr Res 1995; 37:220
36. Papo MC, Paczan PR, Fuhrman BP, et al: Perfluorocarbon-associated gas exchange improves oxygenation, lung mechanics, and survival in a model of adult respiratory distress syndrome. Crit Care Med 1996; 24:466-474
37. Baden HP, Mellema JD, Bratton SL, et al: High frequency oscillation ventilation with partial liquid ventilation in a model of acute respiratory failure. Crit Care Med 1997; 25:299-302
38. Jones CA, Cayabyab RG, Kwong KY, et al: Undetectable interleukin (IL)-10 and persistent expression early in hyaline membrane disease: A possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39:966-975
39. Munshi UK, Niu JO, Siddiq MM, et al: Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 1997; 24:331-336
40. Groneck P, Schmale J, Soditt V, et al: Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease. Pediatr Pulmonol 2001; 31:331-338
41. Baba A, Kim YK, Zhang H, et al: Perfluorocarbon blocks tumor necrosis factor-a-induced interleukin-8 release from alveolar epithelial cells in vitro. Crit Care Med 2000; 28:1113-1118
42. Nakstad B, Wolfson MR, Kahler H, et al: Perfluorochemical liquids modulate cell-mediated inflammatory responses. Crit Care Med 2001; 29:1731-1737
43. Koch T, Ragaller M, Haufe CM, et al: Perfluorohexane attenuates proinflammatory and procoagulatory response of activated monocytes and alveolar macrophages. Anesthesiology 2001; 94:101-109
44. Colton DM, Till GO, Johnson KJ, et al: Neutrophil accumulation is reduced during partial liquid ventilation. Crit Care Med 1998; 26:1716-1724
45. Rotta AT, Steinhorn DM: Partial liquid ventilation reduces pulmonary neutrophil accumulation in an experimental model of systemic endotoxemia and acute lung injury. Crit Care Med 1998; 26:1707-1715
46. Williams EA, Welty SE, Geske RS, et al: Liquid lung ventilation reduces neutrophil sequestration in a neonatal swine model of cardiopulmonary bypass. Crit Care Med 2001; 29:789-795
47. Merz U, Klosterhalfen B, Kellinghaus M, et al: Effects of single and multiple doses of perfluorocarbon in comparison with continuous partial liquid ventilation on gas exchange and lung pathology in newborn surfactant-depleted pigs. Crit Care Med 2001; 29:645-651
48. Miller TF, Milestone BN, Stern RG, et al: Effect of single versus multiple dosing on perfluorochemical distribution and elimination profile during partial liquid ventilation. Pediatr Pulmonol 1999; 27:410-418
49. Wiedemann HP, Schuster DP, Fessier H, et al: A multicenter, randomized, feasibility study of two doses of perflubron for partial liquid ventilation in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 159:A80